FMP
Nutriband Inc.
NTRB
NASDAQ
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
5.68 USD
-0.16 (-2.82%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Gareth Sheridan
sector
Healthcare
industry
Biotechnology
website
https://nutriband.comexchange
NASDAQ
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 an...
CIK
0001676047
ISIN
US67092M2089
CUSIP
67092M208
Address
121 South Orange Avenue
Phone
407 377 6695
Country
US
Employee
13
IPO Date
Oct 1, 2021
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
NTRB Financial Summary
CIK
0001676047
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
67092M208
ISIN
US67092M2089
Country
US
Price
5.68
Beta
0.95
Volume Avg.
65.81k
Market Cap
63.08M
Shares
-
52-Week
3.3-11.78
DCF
4.7
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-8
P/B
-
Website
https://nutriband.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NTRB News
It looks like there's no news available.
